Turkmenistan vs United Kingdom of Great Britain and Northern Ireland: Treatment success rate: XDR-TB cases
Turkmenistan
67
in 2022
United Kingdom of Great Britain and Northern Ireland
67
in 2022
Turkmenistan rank
42nd
United Kingdom of Great Britain and Northern Ireland rank
42nd
Treatment success rate: XDR-TB cases over time
- Turkmenistan
- United Kingdom of Great Britain and Northern Ireland
How they compare
Turkmenistan currently reports 67 against 67 in United Kingdom of Great Britain and Northern Ireland, a difference of 0.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was Turkmenistan ahead.
Turkmenistan ranks 42nd and United Kingdom of Great Britain and Northern Ireland ranks 42nd of 82 countries.
United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Turkmenistan | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 40.33 | 49.33 | 9 | United Kingdom of Great Britain and Northern Ireland |
| 2020s | 63 | 69 | 6 | United Kingdom of Great Britain and Northern Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Turkmenistan or United Kingdom of Great Britain and Northern Ireland?
- Turkmenistan, at 67 against 67 in United Kingdom of Great Britain and Northern Ireland as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between Turkmenistan and United Kingdom of Great Britain and Northern Ireland?
- 0, with Turkmenistan ahead.
- How many years of comparable data are there for Turkmenistan and United Kingdom of Great Britain and Northern Ireland?
- 6 years are reported by both, from 2017 to 2022.
- How do Turkmenistan and United Kingdom of Great Britain and Northern Ireland rank globally for treatment success rate: xdr-tb cases?
- Turkmenistan ranks 42nd and United Kingdom of Great Britain and Northern Ireland ranks 42nd of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.